What is Abbott's D&A?

Abbott (ABT) reported D&A of $422M in Q4 2025.

How has Abbott's D&A changed year-over-year?

Abbott's D&A decreased by 9.2% year-over-year, from $465M to $422M.

What is the long-term trend for Abbott's D&A?

Over 4 years (2021 to 2025), Abbott's D&A has grown at a -4.8% compound annual growth rate (CAGR), from $2.05B to $1.68B.

Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.

Abbott ABT D&A

Discontinued — last reported Q4 '25

D&A at other companies

HaemoneticsHAE

$27.32M-3.2%

ArtivionAORT

$6.34M+16.4%

Merit Medical SystemsMMSI

$30.5M+4.1%

AngioDynamicsANGO

$2.67M+2.7%

MedtronicMDT

$716M-14.8%

DexComDXCM

——

Segments

By segment

See full

Diagnostic Products$144M+14.3%

Medical Devices$100M+13.6%

Nutritional Products$50M+19.0%

Established Pharmaceuticals$30M+30.4%

Other financials

Income statement

See full

Revenue$11.2B+7.8%

Gross profit$6.3B+6.5%

Operating income$1.3B-20.6%

Net income$1.1B-18.7%

EPS (diluted)$0.61-19.7%

Balance sheet

See full

Cash & equivalents$6.8B+4.1%

Total debt$34.0B+157%

Total equity$52.1B+6.7%

Total assets$110.43B+35.6%

Cash flow

See full

Operating cash flow$1.3B-7.2%

CapEx$399.0M-17.6%

Free cash flow$916.0M-1.8%

Valuation

See full

Market cap$162.41B-29.8%

Enterprise value$189.65B-20.3%

P/E25.9×+8.7×

P/S3.6×-1.9×

Profitability

See full

Gross margin56.3%+0.4pp

Operating margin17.1%+0.2pp

Net margin13.9%-18.0pp

FCF margin16.3%+0.6pp

Returns & leverage

See full

Return on equity12.4%-18.4pp

Debt / equity0.7×+0.4×

Current ratio1.4×-0.4×

Where this comes from

Reported directly by Abbott in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The official record: Abbott’s 10-K, filed February 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Abbott's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Abbott's D&A?: Abbott (ABT) reported D&A of $422M in Q4 2025.
How has Abbott's D&A changed year-over-year?: Abbott's D&A decreased by 9.2% year-over-year, from $465M to $422M.
What is the long-term trend for Abbott's D&A?: Over 4 years (2021 to 2025), Abbott's D&A has grown at a -4.8% compound annual growth rate (CAGR), from $2.05B to $1.68B.
What does D&A mean?: Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.